USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NEWLINK GENETICS CORPORATION
Address:
NEWLINK GENETICS CORPORATION
2901 S LOOP DR, BLDG 3, STE 3900
AMES, IA 50010
Phone:
N/A
URL:
N/A
EIN:
421491350
DUNS:
10664329
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $776,920.00 3
STTR Phase I $363,483.00 1

Award List:

VmatchNL - a user-friendly graphical interface for large-scale genome analysis

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$99,722.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The availability of a reference human genome sequence provides the foundation for studying the genetic and molecular basis of human health and disease. Using a variety of modern technologies to study differential gene expression, large numbers of researchers in… More

Exon Boundary Tags (EBTs) for Human Functional Genome Annotation

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$98,414.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The Human Genome Project has brought the field of functional genomics to the forefront of biological and pharmaceutical research. However, deciphering the function(s) of each gene in a high throughput format is complicated by alternative splicing and post-… More

Improved influenza A virus vaccines using alpha-Gal epitope modification

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$578,784.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Humans develop natural antibodies against a sugar molecule called Gal, which is present on proteins and lipids in most other species. These antibodies represent one of the strongest natural barriers to infection with ba cteria, parasites and viruses. NewLink… More

Novel immune-based therapy for leishmaniasis and tuberculosis

Award Year / Program / Phase:
2009 / STTR / Phase I
Award Amount:
$363,483.00
Agency:
HHS
Principal Investigator:
Research Institution:
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): Indolamine 2,3-deoxygenase enzymes (IDO-1 and IDO-2) play important counter-regulatory roles in the immune system. IDO-mediated tryptophan catabolism induces T cell suppression, which plays a physiological role in suppr essing autoimmune and allergic diseases, as… More